IN2015DN01153A - - Google Patents

Info

Publication number
IN2015DN01153A
IN2015DN01153A IN1153DEN2015A IN2015DN01153A IN 2015DN01153 A IN2015DN01153 A IN 2015DN01153A IN 1153DEN2015 A IN1153DEN2015 A IN 1153DEN2015A IN 2015DN01153 A IN2015DN01153 A IN 2015DN01153A
Authority
IN
India
Prior art keywords
drug delivery
composition
delivery system
present
proteins
Prior art date
Application number
Other languages
English (en)
Inventor
Jens Christoph Thies
George Mihov
Guy Draaisma
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of IN2015DN01153A publication Critical patent/IN2015DN01153A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/44Polyester-amides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L77/00Compositions of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Compositions of derivatives of such polymers
    • C08L77/12Polyester-amides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01Peroxidases (1.11.1)
    • C12Y111/01007Peroxidase (1.11.1.7), i.e. horseradish-peroxidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN1153DEN2015 2012-10-02 2015-02-12 IN2015DN01153A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12186915 2012-10-02
EP13173634 2013-06-25
PCT/EP2013/070543 WO2014053542A1 (en) 2012-10-02 2013-10-02 Drug delivery composition comprising proteins and biodegradable polyesteramides

Publications (1)

Publication Number Publication Date
IN2015DN01153A true IN2015DN01153A (enExample) 2015-06-26

Family

ID=49301494

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1153DEN2015 IN2015DN01153A (enExample) 2012-10-02 2015-02-12

Country Status (7)

Country Link
US (1) US9789189B2 (enExample)
EP (1) EP2903592B1 (enExample)
JP (1) JP6330815B2 (enExample)
CN (1) CN104717962B (enExample)
CA (1) CA2881729C (enExample)
IN (1) IN2015DN01153A (enExample)
WO (1) WO2014053542A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
US9963549B2 (en) 2011-06-23 2018-05-08 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
WO2014053542A1 (en) 2012-10-02 2014-04-10 Dsm Ip Assets B.V. Drug delivery composition comprising proteins and biodegradable polyesteramides
US20150328374A1 (en) * 2012-12-20 2015-11-19 Dsm Ip Assets B.V. Coating comprising polyesteramide copolymers for drug delivery
EP3233067B1 (en) 2014-12-18 2019-11-06 DSM IP Assets B.V. Drug delivery system for delivery of acid sensitive drugs
US10500318B1 (en) 2018-07-03 2019-12-10 Temple Therapeutics BV Dosing regimens for treating hypoxia-associated tissue damage
AU2020232314C1 (en) * 2019-03-05 2024-03-28 Alcon Inc. Pharmaceutical compositions for treating ocular diseases or disorders
EP4333828A1 (en) 2021-05-07 2024-03-13 Temple Therapeutics BV Methods of treating fibrosis and hypoxia-associated damage to peripheral nerves
WO2025163204A1 (en) 2024-02-01 2025-08-07 Temple Therapeutics BV Glutamine source for use in methods and compositions for reducing or preventing synovial joint adhesions or fibrosis

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550730A (en) 1981-12-07 1985-11-05 Ethicon, Inc. Flexible monofilament surgical sutures comprising poly(polymethylene terephthalate, isophthalate or cyclohexane-1,4-dicarboxylate-co-dimerate)
EP0926184A1 (en) 1997-12-25 1999-06-30 Mitsui Chemicals, Inc. Process for production of polyamino acid derivative
JP2002519333A (ja) 1998-06-30 2002-07-02 アムジエン・インコーポレーテツド 生物学的に活性な物質の徐放運搬のための感熱性生分解性ヒドロゲル
US7304122B2 (en) 2001-08-30 2007-12-04 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US6503538B1 (en) * 2000-08-30 2003-01-07 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
US20040170685A1 (en) 2003-02-26 2004-09-02 Medivas, Llc Bioactive stents and methods for use thereof
JP2005139139A (ja) 2003-11-07 2005-06-02 Idemitsu Technofine Co Ltd 化粧料組成物
CN101426530B (zh) 2004-05-12 2012-03-07 梅迪沃什有限公司 创伤愈合聚合物组合物及其使用方法
US20050271700A1 (en) 2004-06-03 2005-12-08 Desnoyer Jessica R Poly(ester amide) coating composition for implantable devices
EP2216026B1 (en) 2004-07-12 2016-04-20 Allergan, Inc. Ophthalmic compositions and uses for treating ophthalmic conditions
US7390497B2 (en) 2004-10-29 2008-06-24 Advanced Cardiovascular Systems, Inc. Poly(ester amide) filler blends for modulation of coating properties
US20060159918A1 (en) 2004-12-22 2006-07-20 Fiber Innovation Technology, Inc. Biodegradable fibers exhibiting storage-stable tenacity
CN100551950C (zh) 2005-03-21 2009-10-21 中国科学院成都有机化学有限公司 一种可降解聚酯酰胺共聚物的制备方法
JP5192384B2 (ja) 2005-09-22 2013-05-08 メディバス エルエルシー ビス−(α−アミノ)−ジオール−ジエステル含有ポリ(エステルアミド)およびポリ(エステルウレタン)組成物および使用の方法
JP5178520B2 (ja) 2005-09-22 2013-04-10 メディバス エルエルシー 固体ポリマー送達組成物およびその使用法
CA2670355A1 (en) * 2005-11-21 2008-04-24 Medivas, Llc Polymer particles for delivery of macromolecules and methods of use
US8974815B2 (en) 2005-12-16 2015-03-10 Cornell University Fibrous membrane for biomedical application based on poly(ester-amide)s
TWI376239B (en) 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
EP2019645A4 (en) 2006-05-02 2013-03-06 Medivas Llc RELEASE OF OPHTHALMOLOGICAL ACTIVITIES OUTSIDE OR WITHIN THE EYE
EP2021141A4 (en) 2006-05-09 2013-07-03 Medivas Llc BIODEGRADABLE WATER SOLUBLE POLYMERS
US8936780B2 (en) 2006-08-30 2015-01-20 Advanced Cardiovascular Systems, Inc. Stimuli responsive polyester amide particles
KR101422298B1 (ko) 2006-09-08 2014-08-13 가부시키가이샤 니콘 마스크, 노광 장치, 노광 방법 및 그 노광 장치 또는 노광 방법을 이용한 디바이스 제조 방법
CA2685965A1 (en) 2007-03-30 2008-10-09 Medivas, Llc Bioabsorbable elastomeric polymer networks, cross-linkers and methods of use
US9737638B2 (en) 2007-06-20 2017-08-22 Abbott Cardiovascular Systems, Inc. Polyester amide copolymers having free carboxylic acid pendant groups
EP2623132B1 (en) 2007-07-18 2016-03-30 The Board of Trustees of the University of Illionis Temporal release of growth factors from 3d micro rod scaffolds for tissue regeneration
IN2012DN02078A (enExample) * 2009-10-16 2015-08-21 Dsm Ip Assets Bv
EP2571526B1 (en) 2010-05-17 2019-03-13 Novaer Holdings, Inc. Drug delivery devices for delivery of ocular therapeutic agents
EP2705182B1 (en) 2011-05-02 2018-10-31 DSM IP Assets B.V. Fiber comprising a biodegradable polymer
WO2012150255A1 (en) 2011-05-02 2012-11-08 Dsm Ip Assets B.V. Bis-(alpha-amino-diol-diester) containing polyesteramide for ophtamology
US9963549B2 (en) 2011-06-23 2018-05-08 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
EP2790667B1 (en) 2011-12-16 2017-03-22 DSM IP Assets B.V. Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent
WO2014053542A1 (en) 2012-10-02 2014-04-10 Dsm Ip Assets B.V. Drug delivery composition comprising proteins and biodegradable polyesteramides
EP2911647B1 (en) 2012-10-23 2018-03-07 DSM IP Assets B.V. Process for the manufacturing of a multilayer drug delivery construct
US10538864B2 (en) 2012-10-24 2020-01-21 Dsm Ip Assets, B.V. Fibers comprising polyesteramide copolymers for drug delivery
US20150328374A1 (en) 2012-12-20 2015-11-19 Dsm Ip Assets B.V. Coating comprising polyesteramide copolymers for drug delivery

Also Published As

Publication number Publication date
EP2903592A1 (en) 2015-08-12
EP2903592B1 (en) 2019-01-23
US20150216987A1 (en) 2015-08-06
JP2015534557A (ja) 2015-12-03
CA2881729A1 (en) 2014-04-10
US9789189B2 (en) 2017-10-17
CN104717962B (zh) 2017-07-21
JP6330815B2 (ja) 2018-05-30
CN104717962A (zh) 2015-06-17
WO2014053542A1 (en) 2014-04-10
CA2881729C (en) 2021-05-04

Similar Documents

Publication Publication Date Title
IN2015DN01153A (enExample)
MX2011004994A (es) Metodo para preparar microesferas y microesferas producidas por el mismo.
Rawlinson et al. Antibacterial effects of poly (2-(dimethylamino ethyl) methacrylate) against selected gram-positive and gram-negative bacteria
MY169349A (en) Biodegradable, semi-crystalline, phase separated, thermoplastic multi-block copolymers for controlled release of biologically active compounds
CL2013003331A1 (es) Tableta de liberacion inmediata a prueba de alteracion que comprende (i) una matriz, y (ii) una pluralidad de material particulado, que comprende un opiaceo y un polimero de oxido de polietileno de mas de 20.000 g/mol, donde el multiparticulado forma una fase discontinua dentro de la matriz.
EP4502052A3 (en) Polymers and nanogel materials and methods for making and using the same
MX2009008952A (es) Microesferas que comprenden una matriz de sustancia activa resistente a jugo gastrico.
NZ705384A (en) Composition for treating hyperlipidemia comprising oxyntomodulin derivative
MX2013012934A (es) Nanoparticulas polimericas para el suministro de farmacos.
MX2009010070A (es) Composiciones y metodos para controlar el crecimiento de microorganismos en sistemas acuosos.
ES2571735T3 (es) Composiciones biodegradables que soportan grupo hidrófilo colgante y dispositivos relacionados
BR112014014599A2 (pt) polímeros de alfa-aminoamidina e uso dos mesmos
EA201170039A1 (ru) Полимерные частицы, нагруженные лекарственным средством, и способы их получения и применения
Holcapkova et al. Effect of polyethylene glycol plasticizer on long‐term antibacterial activity and the release profile of bacteriocin nisin from polylactide blends
EA200971132A1 (ru) Фармацевтическая композиция с пролонгированным высвобождением, приготовленная из микрочастиц
ES2530457T3 (es) Secuencias peptídicas, su forma ramificada y uso de estas para aplicaciones antimicrobianas
BR112012015184A2 (pt) "processo para preparar um éster cíclico, copolímero, micropartícula,e, micela de polímero"
BR112012030344A2 (pt) metilestireno contendo grupo hidroxila e polímeros incorporando o mesmo
AR050163A1 (es) Microcapsulas de liberacion activada del material contenido en su nucleo
WO2012050879A3 (en) Methods for processing microspheres, microspheres processed thereby, and uses thereof
PE20110876A1 (es) Formulacion de deposito de octreotida con niveles de exposicion constantemente altos
WO2012092486A3 (en) Modified release benzimidazole formulations
FR2958120B1 (fr) Nouvelle composition d'enrobage a base de copolymeres, ses utilisations et son procede de preparation
MX2013005275A (es) Sistema de liberacion de particulas de polimero auto-ensamble.
SI1564242T1 (sl) Postopek dodajanja sintetičnih vlaken in polimerov z enkapsulacijo aditivov v nanopore